Overview

Evaluation of MST-188 in Acute Lower Limb Ischemia

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of MST-188 in subjects receiving catheter-directed rt-PA for acute lower limb ischemia and to evaluate whether treatment with MST-188 results in more rapid thrombolysis of the occlusion and more rapid tissue perfusion in the effected blood vessel.
Phase:
Phase 2
Details
Lead Sponsor:
Mast Therapeutics, Inc.
Treatments:
Tissue Plasminogen Activator